Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell TransplantationChronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Leukemia, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Myeloproliferative Disorders, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, acute myeloid leukemia, anemia, bone marrow disorder, chronic myelomonocytic leukemia, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoma, lymphoproliferative syndrome, myelodysplastic syndrome, myelodysplastic syndrome with excess blasts, myelodysplastic syndrome with single lineage dysplasia, myelodysplastic/myeloproliferative disease, myeloid leukemia, neoplasm, primary myelofibrosisRecruitingPhase 22026-03-17NCT06859424

3 results · Page 1 of 1

Swipe the table sideways for more columns.

13 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
City of HopeDuarteUnited States238
Dana-Farber Cancer InstituteBostonUnited States1
Fred Hutchinson Cancer CenterSeattleUnited States250
Karmanos Cancer InstituteDetroitUnited States153
MD AndersonHoustonUnited States56
Memorial Sloan KetteringNew YorkUnited States27
Oregon Health & Science UniversityPortlandUnited States261
StanfordPalo AltoUnited States11
University of Alabama BirminghamBirminghamUnited States20
University of Kansas Medical CenterWestwoodUnited States7
University of MiamiMiamiUnited States327
University of North CarolinaChapel HillUnited States38
University of VirginiaCharlottesvilleUnited States136